NETSCOUT Delivers Double-Digit Energy Savings for Data Center Observability Solutions
Data center energy consumption is escalating at an alarming rate, driven by digital transformation and advancements in artificial intelligence. According to a recent International Energy Agency (IEA) report, global data center electricity consumption is projected to more than double by 2030, including U.S. data centers consuming more electricity than for the production of aluminum, steel, cement, chemicals, and all other energy-intensive goods combined.
NETSCOUT's nGeniusONE and InfiniStreamNG solutions are purpose-built to deliver comprehensive network visibility and analytics. Unlike multi-appliance architectures that require numerous components for different functionalities, NETSCOUT's approach centralizes capabilities within the InfiniStreamNG probe, leading to a more streamlined and energy-efficient deployment.
Key benefits of this approach include:
Quantifiable Energy and Cost Reductions: NETSCOUT's InfiniStream solution has demonstrated an average reduction in electricity consumption of 23% based on analysis of ten customers covering more than 500 InfiniStreamNG devices, with no trade-off in optimized performance.
Reduced Rack Space and Simplified Deployments: InfiniStreamNG's consolidated architecture reduces the number of physical appliances. This smaller footprint not only saves valuable rack space but also substantially lowers energy consumption.
Intelligent Data Processing: Data filtering capabilities enable organizations to collect and process data only from necessary protocols and ports, reducing required compute and storage resources, as well as overall energy usage.
'By applying our deep expertise in hardware technology, we've optimized the InfiniStreamNG platform to reduce complexity, lower energy and operational costs – while delivering the network visibility required to manage today's increasingly complex environments,' said Ray Jones, senior director, platform product management at NETSCOUT. "This capability is critical as organizations face mounting pressure to improve data center efficiency in response to explosive AI-driven growth."
NETSCOUT's commitment to sustainability extends beyond product design to its own operations. The company has set science-based emissions reduction targets, committing to reduce absolute Scope 1 (direct emissions) greenhouse gas emissions by 57.4% and absolute Scope 2 (indirect emissions from electricity) greenhouse gas emissions by 42% by FY2030 from an FY2022 baseline. These targets have been validated by the Science-Based Targets initiative (SBTi), and NETSCOUT is already making measurable progress toward these goals or exceeding them.
For more information about NETSCOUT's leading approach to sustainability by design, visit our website.
About NETSCOUT
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) protects the connected world from cyberattacks and performance and availability disruptions through its unique visibility platform and solutions powered by its pioneering deep packet inspection at scale technology. NETSCOUT serves the world's largest enterprises, service providers, and public sector organizations. Learn more at www.netscout.com or follow @NETSCOUT on LinkedIn, X, or Facebook.
©2025 NETSCOUT SYSTEMS, INC. All rights reserved. Third-party trademarks mentioned are the property of their respective owners.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock experienced a volatile trading session on Monday, after the company announced positive topline results from its Phase 2 RADIANT study evaluating vormatrigine in patients with focal onset seizures and generalized epilepsy. The stock initially surged on the news, but then reversed course and is currently trading down approximately 9%. The central nervous system (CNS) disorders-focused company said the topline results from the Phase 2 RADIANT study included data from 37 patients.'These findings build on our earlier clinical data showing a differentiated profile for vormatrigine as a fast-acting, no-titration, once-daily oral drug with no requirement to be taken with food, and a favorable DDI profile, all of which are unseen in ASMs currently in the market or in development,' said Marcio Souza, president and CEO of Praxis. In an investor presentation on the company website, Praxis noted that the trial showed a median seizure reduction of around 56.3%, with 60% of the patients achieving at least a 50% reduction in seizures. This positive outcome has encouraged the company to move forward with a Phase 2/3 trial, even though 23% of patients discontinued the study. 54% of patients achieved at least a 50% seizure reduction threshold in Week 1 and 67% in Week 8. In the last month of the dataset, 22% of the patients experienced a 100% reduction in seizure frequency. The company added that most adverse events were mild to moderate and transient. All severe and serious adverse events (AEs) were recovered and resolved. The investor presentation noted that the investigators had the option to reduce the dose of the background medication to manage AEs; when done (6 patients), no discontinuation was observed. The company said it is on track to complete the pivotal, 12-week POWER1 study in the fourth quarter of 2025 and, based on the results from RADIANT, it expects to initiate the POWER2 study shortly. On Monday, the company reported cash and investments of approximately $447 million and maintains a cash runway into 2028. In July, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for Praxis Precision's relutrigine, a sodium channel functional state modulator for pediatric use for SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs). The EMBOLD cohort 2 pivotal trial is on track for topline results in the first half of 2026, with NDA filing to follow. Praxis has recently initiated the EMERALD study investigating relutrigine broadly in DEEs. Price Action: PRAX stock is trading lower by 9.51% to $48.95 at last check Monday. Read Next:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
10 minutes ago
- Yahoo
Global M&A hits $2.6 trillion peak year-to-date, boosted by AI and quest for growth
By Emma-Victoria Farr and Amy-Jo Crowley LONDON (Reuters) - Global dealmaking has reached $2.6 trillion, the highest for the first seven months of the year since the 2021 pandemic-era peak, as a quest for growth in corporate boardrooms and the impact of a surge in AI activity has overcome the uncertainty caused by U.S. tariffs. The number of transactions to August 1 is 16% lower than the same time last year, but their value is 28% higher, according to Dealogic data, boosted by U.S. megadeals valued at more than $10 billion. They include Union Pacific Corp's proposed $85 billion acquisition of small rival Norfolk Southern and OpenAI's $40 billion funding round led by Softbank Group. The upsurge will be a relief to bankers who began the year with expectations the administration of U.S. President Donald Trump would lead to a wave of consolidation. Instead, his trade tariffs and geopolitical uncertainty made companies pause until renewed confidence in corporate boardrooms and the U.S. administration's anti-trust agenda changed the mood. "What you're seeing in terms of deal rationale for transactions right now is that it's heavily growth-motivated, and it's increasing," Andre Veissid, EY Global Financial Services Strategy and Transactions Leader, told Reuters. "Whether it's artificial intelligence, the change in the regulatory environment, we see our clients not wanting to be left behind in that race and that's driving activity." Compared with August 2021, when investors, rebounding from pandemic lockdowns drove the value of deals to $3.57 trillion, this year's tally is nearly a $1 trillion, or 27%, lower. Still deal-makers at JPMorgan Chase JP Morgan Chase have said there is more to come, with companies pursuing bigger deals in the second half of the year as executives adapt to volatility. "People have got used to the prevailing uncertainty, or maybe the unpredictability post-U.S. election is just more predictable now," Simon Nicholls, co-head of Slaughter and May Corporate and M&A group, said. Nigel Wellings, Partner at Clifford Chance said the market was moving beyond tariffs. "Boardrooms are seeing the M&A opportunity of a more stable economic environment and positive regulatory signals. But it is not a frothy market." FROM HEALTH TO TECH While the healthcare sector drove M&A in the years after the pandemic, the computer and electronics industry has produced more takeover bids in the U.S. and the United Kingdom in the last two years, according to Dealogic. Artificial intelligence is expected to drive more dealmaking. M&A activity has increased around data centre usage, such as Samsung's $1.7 billion acquisition of Germany's FlaktGroup, a data centre cooling specialist. Palo Alto Networks $25 billion deal for Israeli cybersecurity peer CyberArk was the largest deal in Europe, Middle East and Africa so far this year as rising AI-driven threats push companies to adopt stronger defences. Private equity, which had been sitting on the sidelines, has once again been active, with Sycamore Partners' $10 billion deal to take private Walgreens Boots Alliance and a sweetened $6.4 billion offer from Advent for UK scientific instrument maker Spectris. The U.S. was the biggest market for M&A, accounting for more than half of the global activity. Asia Pacific's dealmaking doubled over the same year to date period last year, outpacing the EMEA region. Sign in to access your portfolio
Business Wire
12 minutes ago
- Business Wire
Fortifi Capital Surpasses $175 Million in Small Business Funding as It Marks Two-Year Anniversary
NEW YORK--(BUSINESS WIRE)--Fortifi Capital, a fast-growing provider of working capital solutions for small businesses, today announced it has surpassed $175 million in total funding deployed across the United States. The milestone coincides with the company's two-year anniversary, underscoring rapid growth and strong demand for flexible financing options among entrepreneurs. Fortifi Capital Surpasses $175 Million in Small Business Funding as It Marks Two-Year Anniversary Share Founded in August 2023, Fortifi Capital has quickly become a trusted capital partner for small and mid-sized businesses seeking speed, transparency, and personalized service. With headquarters in New York and regional offices in White Plains, Garden City, and Somerset, NJ, the firm has supported thousands of businesses across a wide range of industries. As part of its growth strategy, Fortifi is investing in proprietary technology aimed at improving marketing, streamlining operations, and enhancing the customer experience. These initiatives will support continued scale while maintaining the company's high-touch service model. Fortifi Capital's leadership team brings over a decade of experience in the alternative finance space, combining deep industry expertise with a commitment to innovation. With $175 million deployed in just two years and a robust infrastructure in place, Fortifi Capital is positioned for continued expansion in the small business finance sector. About Fortifi Capital Fortifi Capital provides fast, flexible, and transparent working capital solutions to small businesses nationwide. Founded in 2023, the company has funded over $175 million to date and continues to invest in technology and service to meet the evolving needs of American entrepreneurs. Fortifi is headquartered in New York with regional offices in White Plains, Garden City, and Somerset, NJ.
